Introduction - In addition to providing all the essential nutrients for the neonate, milk is also a vector of a wide range of immune effector molecules. It has been recently observed that milk IgA can be successfully used for prophylactic or therapeutic treatment against infections by Candida albicans and Helicobacter pylori, which represent serious risk for the health of the digestive system. IgA is the major immunoglobulin present in human milk, but it is 4-5 times less abundant in bovine milk. Since bovine milk is the most consumed milk worldwide, the detection of factors affecting the level of IgA in bovine milk offers great potential to add value to the dairy products. Aim - The present study aimed at evaluating the effect of day in milk and parity on IgA level in colostrum and milk of dairy cows. Materials and methods - Seven primiparous and 7 multiparous healthy Fresian cows were studied for 3 months after calving. All the cows were fed the same experimental diet, over the study period. On day 0, 1, 3, 7, 30, 60 and 90 of lactation, milk yield was recorded, colostrum and milk samples were taken. Colostrum and milk samples were obtained mixing morning and evening milkings and then tested for protein, fat, lactose, casein and urea content, somatic cell count and total bacterial count (TBC). Skimmed colostrum and milk were tested for IgA by ELISA. Data were evaluated by ANOVA. Results - Maximum milk production was observed on day 30 for multiparous cows (43.3 L/d) and on day 60 for the primiparous ones (40.5 L/d). In both groups, the highest levels of IgA were found at calving. The day after, colostrum IgA concentration dramatically decreased, remaining at low levels for the rest of the study period. On calving, IgA level was higher in the colostrum from multiparous than primiparous cows (782 vs. 640 µg/ml; P<0.01). On day 0, 60 and 90, TBC was higher in milk from multiparous than primiparous cows (P=0.06). Between 7 and 90 days of lactation, TBC was negatively correlated whether with milk IgA levels (r = -0.506, P<0.01; r = -0.396, P<0.05 for multiparous and primiparous cows, respectively) and with milk IgA daily yield (r = -0.504, P<0.01; r = -0.501, P<0.01). Conclusions - This research gives a description of the pattern of IgA in colustrum and milk of dairy cows, during the first months of lactation, providing valuable information to maximize the positive effects of milk consumption on consumer health.

The functional milk / D. Magistrelli, D. Meggiolaro, M.E. Marescotti, F. Rosi. ((Intervento presentato al 5. convegno Forum Internazionale di Nutrizione Pratica : NutriMI 2011 tenutosi a Rho (MI) nel 2011.

The functional milk

D. Magistrelli;D. Meggiolaro;M.E. Marescotti;F. Rosi
2011

Abstract

Introduction - In addition to providing all the essential nutrients for the neonate, milk is also a vector of a wide range of immune effector molecules. It has been recently observed that milk IgA can be successfully used for prophylactic or therapeutic treatment against infections by Candida albicans and Helicobacter pylori, which represent serious risk for the health of the digestive system. IgA is the major immunoglobulin present in human milk, but it is 4-5 times less abundant in bovine milk. Since bovine milk is the most consumed milk worldwide, the detection of factors affecting the level of IgA in bovine milk offers great potential to add value to the dairy products. Aim - The present study aimed at evaluating the effect of day in milk and parity on IgA level in colostrum and milk of dairy cows. Materials and methods - Seven primiparous and 7 multiparous healthy Fresian cows were studied for 3 months after calving. All the cows were fed the same experimental diet, over the study period. On day 0, 1, 3, 7, 30, 60 and 90 of lactation, milk yield was recorded, colostrum and milk samples were taken. Colostrum and milk samples were obtained mixing morning and evening milkings and then tested for protein, fat, lactose, casein and urea content, somatic cell count and total bacterial count (TBC). Skimmed colostrum and milk were tested for IgA by ELISA. Data were evaluated by ANOVA. Results - Maximum milk production was observed on day 30 for multiparous cows (43.3 L/d) and on day 60 for the primiparous ones (40.5 L/d). In both groups, the highest levels of IgA were found at calving. The day after, colostrum IgA concentration dramatically decreased, remaining at low levels for the rest of the study period. On calving, IgA level was higher in the colostrum from multiparous than primiparous cows (782 vs. 640 µg/ml; P<0.01). On day 0, 60 and 90, TBC was higher in milk from multiparous than primiparous cows (P=0.06). Between 7 and 90 days of lactation, TBC was negatively correlated whether with milk IgA levels (r = -0.506, P<0.01; r = -0.396, P<0.05 for multiparous and primiparous cows, respectively) and with milk IgA daily yield (r = -0.504, P<0.01; r = -0.501, P<0.01). Conclusions - This research gives a description of the pattern of IgA in colustrum and milk of dairy cows, during the first months of lactation, providing valuable information to maximize the positive effects of milk consumption on consumer health.
7-apr-2011
bovine milk ; IgA
Settore VET/01 - Anatomia degli Animali Domestici
Settore AGR/19 - Zootecnica Speciale
Settore AGR/17 - Zootecnica Generale e Miglioramento Genetico
Ministero delle Politiche Agricole Alimentari e Forestali
Comune di Milano
Ministero della Salute
Università degli Studi di Milano
Istituto Superiore di Sanità
Consiglio Nazionale delle Ricerche
The functional milk / D. Magistrelli, D. Meggiolaro, M.E. Marescotti, F. Rosi. ((Intervento presentato al 5. convegno Forum Internazionale di Nutrizione Pratica : NutriMI 2011 tenutosi a Rho (MI) nel 2011.
Conference Object
File in questo prodotto:
File Dimensione Formato  
2011 NUTRIMI The functional milk.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 30.62 kB
Formato Adobe PDF
30.62 kB Adobe PDF Visualizza/Apri
2011 NutriMi_2011 Prima Giornata Nutrizione Animale.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 334.64 kB
Formato Adobe PDF
334.64 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/156512
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact